AS-Probionorm

DRUG2 trials

Sponsors

Industrial Microbiology LLP

Conditions

DysbacteriosisIntestinal Infections

Phase 1

Study of the Safety and Tolerability of the Broad-spectrum Probiotic Medicine AS-Probionorm

CompletedNCT06252831

Industrial Microbiology LLPDysbacteriosis, Intestinal Infections

Start: 2023-09-02End: 2023-10-14Updated: 2024-02-12

Phase 2

INVESTIGATION of the EFFICACY and SAFETY of the DRUG AS-PROBIONORM

CompletedNCT06886399

Industrial Microbiology LLPDysbacteriosis, Intestinal Infections

Start: 2024-07-22End: 2024-08-11Updated: 2025-03-20